Siegfried Holding AG
SIX:SFZN
Intrinsic Value
Siegfried Holding AG engages in the development and manufacture of active pharmaceutical ingredients for pharmaceutical clients with research and development programs, related intermediates, and contr... [ Read More ]
The intrinsic value of one SFZN stock under the Base Case scenario is 1 114.39 CHF. Compared to the current market price of 866 CHF, Siegfried Holding AG is Undervalued by 22%.
Valuation Backtest
Siegfried Holding AG
Run backtest to discover the historical profit from buying and selling SFZN stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Siegfried Holding AG
Current Assets | 983.2m |
Cash & Short-Term Investments | 56.6m |
Receivables | 431m |
Other Current Assets | 495.5m |
Non-Current Assets | 878.3m |
Long-Term Investments | 577k |
PP&E | 801.1m |
Intangibles | 43.9m |
Other Non-Current Assets | 32.8m |
Current Liabilities | 397.8m |
Accounts Payable | 98.8m |
Accrued Liabilities | 120.5m |
Other Current Liabilities | 178.5m |
Non-Current Liabilities | 625.5m |
Long-Term Debt | 445m |
Other Non-Current Liabilities | 180.5m |
Earnings Waterfall
Siegfried Holding AG
Revenue
|
1.3B
CHF
|
Cost of Revenue
|
-951.1m
CHF
|
Gross Profit
|
320.4m
CHF
|
Operating Expenses
|
-146.2m
CHF
|
Operating Income
|
174.2m
CHF
|
Other Expenses
|
-62.1m
CHF
|
Net Income
|
112.1m
CHF
|
Free Cash Flow Analysis
Siegfried Holding AG
SFZN Profitability Score
Profitability Due Diligence
Siegfried Holding AG's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
Score
Siegfried Holding AG's profitability score is 54/100. The higher the profitability score, the more profitable the company is.
SFZN Solvency Score
Solvency Due Diligence
Siegfried Holding AG's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Score
Siegfried Holding AG's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SFZN Price Targets Summary
Siegfried Holding AG
According to Wall Street analysts, the average 1-year price target for SFZN is 1 025.47 CHF with a low forecast of 888.8 CHF and a high forecast of 1 181.25 CHF.
Shareholder Return
SFZN Price
Siegfried Holding AG
Average Annual Return | 19.99% |
Standard Deviation of Annual Returns | 32.34% |
Max Drawdown | -32% |
Market Capitalization | 3.7B CHF |
Shares Outstanding | 4 289 350 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Siegfried Holding AG engages in the development and manufacture of active pharmaceutical ingredients for pharmaceutical clients with research and development programs, related intermediates, and controlled substances. The company is headquartered in Zofingen, Aargau and currently employs 3,432 full-time employees. The firm produces both drug substances and drug products. The drug substance portfolio includes contract development and manufacturing of both active pharmaceutical ingredients (APIs) and intermediates. The drug products portfolio comprises licensing and contract or co-development and manufacturing of oral solids and steriles. The firm's products and substances are developed for treatment of hypertension, benign prostate hyperplasia, depression, chronic myeloid leukemia, glaucoma, asthma, schizophrenia and bipolar disorders and diabetes. The firm operates production facilities in Switzerland, Germany, France, Malta, the United States and China.
Contact
IPO
Employees
Officers
The intrinsic value of one SFZN stock under the Base Case scenario is 1 114.39 CHF.
Compared to the current market price of 866 CHF, Siegfried Holding AG is Undervalued by 22%.